<p>Eighteen EDRN developed biomarker tests are available in Clinical Laboratory Improvement Amendments (CLIA) approved laboratories. <a href="fda-approved-tests-and-devices">Eight diagnostic tests or devices supported by the EDRN</a> have also been approved by the U.S. Food and Drug Administration for clinical use.</p>
<p>The CLIA-approved tests are shown in the chart below.</p>
<table class="listing biomarkerTable" summary="Biomarker assays, purposes, and EDRN principal investgators responsible for them" style="border-style: solid; float: left;">
<thead>
<tr>
<th>Biomarker Assay</th>
<th>Purpose</th>
<th>EDRN Principal Investigator<br /><em>CLIA Laboratory</em></th>
</tr>
</thead>
<tbody>
<tr>
<td><strong>MiCheck</strong> (Glypican-1 protein and related signaling molecules)</td>
<td>Differentiate aggressive prostate cancer from non-aggressive cancer and no cancer</td>
<td>Daniel Chan, Ph.D.<br /><em>Minomic, Inc.</em></td>
</tr>
<tr>
<td><strong>Videssa</strong> (a multi-protein biomarker blood test)</td>
<td>Distinguish benign from malignant breast lesions</td>
<td>Joshua LaBaer, M.D., and Karen Anderson, M.D.<br /><em>Provista</em></td>
</tr>
<tr>
<td><strong>DetermaVu</strong></td>
<td>Liquid biopsy test intended to facilitate clinical decision making in lung cancer</td>
<td>Louise Showe, Ph.D.<br /><em>OncoCyte</em></td>
</tr>
<tr>
<td><strong>Precepta</strong></td>
<td>(23-gene expression panel) Detection of lung cancer</td>
<td>Avrum Spira, M.D.<br /><em>Veracyte Inc.</em></td>
</tr>
<tr>
<td><a href='@@dataDispatch?subjectURI=http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1125'><strong>Esoguard</strong></a>
(methylated vimentin and cyclin A1)</td>
<td>Detection of Barrett’s esophagus</td>
<td>Sandford Markowitz, M.D.<br /><em>PAVmed</em></td>
</tr>
<tr>
<td><strong>Decipher Prostate Cancer Classifier Test</strong> (<a href='@@dataDispatch?subjectURI=http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1133'>SChLAP1</a> and other lncRNAs)</td>
<td>Determination of prostate cancer aggressiveness</td>
<td>Arul Chinnaiyan, M.D., Ph.D.<br /><em>GenomeDx</em></td>
</tr>
<tr>
<td><strong>Protein panel</strong> (<a href='@@dataDispatch?subjectURI=http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/104'>TIMP1</a>, <a href='@@dataDispatch?subjectURI=http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/167'>LRG1</a>, and <a href='@@dataDispatch?subjectURI=http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/25'>CA19-9</a>)</td>
<td>Detection of pancreatic cancer</td>
<td>Samir Hanash M.D., Ph.D.<br /><em>Cosmos Wisdom</em></td>
</tr>
<tr>
<td><strong>Mucin panel</strong> (<a href='@@dataDispatch?subjectURI=http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1155'>MUC4</a>, <a href='@@dataDispatch?subjectURI=http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1092'>MUC5AC</a>, <a href='@@dataDispatch?subjectURI=http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/20'>MUC16</a> and MUC17)</td>
<td>Detection of pancreatic cancer</td>
<td>Surinder Batra, Ph.D.<br /><em>Sanguine Diagnostic and Therapeutics</em></td>
</tr>
<tr>
<td><a href='@@dataDispatch?subjectURI=http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1075'><strong>MiPS</strong></a> (Mi Prostate Score Urine test), Multiplex analysis of <a href='@@dataDispatch?subjectURI=http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/543'>TMPRSS2:ERG</a> gene fusion, <a href='@@dataDispatch?subjectURI=http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/63'>PCA3</a>, and serum <a href='@@dataDispatch?subjectURI=http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1051'>PSA</a></td>
<td>Detection of prostate cancer</td>
<td>Arul Chinnaiyan, M.D., Ph.D.<br /><em>Gen-Probe</em></td>
</tr>
<tr>
<td><a href='@@dataDispatch?subjectURI=http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1079'><strong>IHC and FISH for TMPRSS2:ERG fusion</strong></a></td>
<td>Detection of prostate cancer</td>
<td>Arul Chinnaiyan, M.D., Ph.D.<br /><em>Roche</em></td>
</tr>
<tr>
<td><a href='@@dataDispatch?subjectURI=http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/116'><strong>GSTP1</strong></a> methylation</td>
<td>Decision making regarding repeat biopsies in prostate cancer</td>
<td>David Sidransky, M.D.<br /><em>OncoMethylome</em></td>
</tr>
<tr>
<td><a href='@@dataDispatch?subjectURI=http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1078'><strong>Mitochondrial deletion</strong></a></td>
<td>Detection of prostate cancer</td>
<td>National Institute of Standards and Technology (NIST)<br /><em>Mitomics</em></td>
</tr>
<tr>
<td><a href='@@dataDispatch?subjectURI=http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/1076'><strong>Proteomic panel</strong></a></td>
<td>Detection of lung cancer</td>
<td>William Rom, M.D., M.P.H.<br /><em>Celera</em></td>
</tr>
<tr>
<td><a href='@@dataDispatch?subjectURI=http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/972'><strong>Aptamer-based markers</strong></a></td>
<td>Detection of lung cancer</td>
<td>William Rom, M.D., M.P.H.<br /><em>Somalogic</em></td>
</tr>
<tr>
<td><a href='@@dataDispatch?subjectURI=http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/548'><strong>80-gene panel</strong></a>†<br />†This panel has been refined; Percepta®, a 23-gene classifier, is now available through Veracyte)</td>
<td>Detection of lung cancer</td>
<td>Avrum Spira, M.D., M.Sc.<br /><em>Allegro/Veracyte</em></td>
</tr>
<tr>
<td><a href='@@dataDispatch?subjectURI=http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/107'><strong>Vimentin methylation</strong> in stool</a></td>
<td>Detection of colon cancer</td>
<td>Sanford Markowitz, M.D., Ph.D.<br /><em>LabCorp</em></td>
</tr>
<tr>
<td><a href='@@dataDispatch?subjectURI=http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/83'><strong>Galectin-3 ligand</strong></a></td>
<td>Detection of advanced adenomas and colon cancer</td>
<td>Robert Bresalier, M.D.<br /><em>BG Medicine</em></td>
</tr>
<tr>
<td><a href='@@dataDispatch?subjectURI=http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/86'><strong>GP73</strong></a></td>
<td>Risk of hepatocellular carcinoma</td>
<td>Timothy Block, Ph.D.<br /><em>Beckman Coulter</em></td>
</tr>
<tr>
<td><a href='@@dataDispatch?subjectURI=http://edrn.jpl.nasa.gov/bmdb/biomarkers/view/53'><strong>8-gene Panel for Barrett’s Esophagus (BE)</strong></a></td>
<td>Progression prediction of BE</td>
<td>Stephen Meltzer, M.D.<br /><em>Diagnovus</em></td>
</tr>
</tbody>
</table>